Calliditas to present at JP Morgan Healthcare Conference

Åsa Hillsten, Head of IR & Sustainability, Calliditas Åsa Hillsten, Head of IR & Sustainability, Calliditas Tel.: +46 76 403 35 43, Email:asa.hillsten@calliditas.com The information was sent for publication, through the agency of the contact person set out above, onJanuary 7, 2024at3:00 p.m. CET. About Calliditas Calliditas Therapeutics is a biopharma company headquartered inStockholm, Sweden, focused on identifying, developing, and commercializing novel...

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact person set out above, on January 7, 2024 at 3:00 p.m. CET.

About Calliditas

Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas' common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT). Visit Calliditas.com for further information.

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/calliditas-to-present-at-jp-morgan-healthcare-conference-302027785.html